APA (7th ed.) Citation

MS, H., A, G., K, G., RJ, S., J, N., M, S., . . . G, G. (2025). Targeting CXCR2 signaling in inflammatory lung diseases: Neutrophil-driven inflammation and emerging therapies. Naunyn-Schmiedeberg's archives of pharmacology, 398(8), 9583. https://doi.org/10.1007/s00210-025-03970-x

Chicago Style (17th ed.) Citation

MS, Hussain, et al. "Targeting CXCR2 Signaling in Inflammatory Lung Diseases: Neutrophil-driven Inflammation and Emerging Therapies." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 8 (2025): 9583. https://doi.org/10.1007/s00210-025-03970-x.

MLA (9th ed.) Citation

MS, Hussain, et al. "Targeting CXCR2 Signaling in Inflammatory Lung Diseases: Neutrophil-driven Inflammation and Emerging Therapies." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 8, 2025, p. 9583, https://doi.org/10.1007/s00210-025-03970-x.